EUVIMEDEUVIMED entdecken
Crossref

Deubiquitinating enzyme OTUD4 stabilizes RBM47 to induce ATF3 transcription: a novel mechanism underlying the restrained malignant properties of ccRCC cells

Ziyao Li, Ye Tian, Huafeng Zong, Xuelei Wang, Dongyang Li, Adili Keranmu, Shiyong Xin, Bowen Ye, Rong Bai, Weihua Chen, Guosheng Yang, Lin Ye und 1 weitere

Apoptosis · 2024

DOI: 10.1007/s10495-024-01953-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Apoptosis, 2024. Verfasst von Ziyao Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Activating Transcription Factor 3, Carcinoma, Renal Cell, Kidney Neoplasms, RNA-Binding Proteins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: China Scholarship Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulation of deubiquitination contributes to various diseases, including cancer, and aberrant expression of deubiquitinating enzymes is involved in carcinoma progression. As a member of the ovarian tumor (OTU) deubiquitinases, OTUD4 is considered a tumor suppressor in many kinds of malignancies. The biological characteristics and mechanisms of OTUD4 in clear cell renal cell carcinoma (ccRCC) remain unclear. The downregulation of OTUD4 in ccRCC was confirmed based on the TCGA database and a validation cohort of 30-paired ccRCC and para-carcinoma samples. Moreover, OTUD4 expression was detected by immunohistochemistry in 50 cases of ccRCC tissues, and patients with lower levels of OTUD4 showed larger tumor size (p = 0.015). TCGA data revealed that patients with high expression of OTUD4 had a longer overall survival rate. In vitro and in vivo studies revealed that downregulation of OTUD4 was essential for tumor cell growth and metastasis in ccRCC, and OTUD4 overexpression inhibited these malignant phenotypes. We further found that OTUD4 sensitized ccRCC cells to Erastin-induced ferroptosis, and ferrostain-1 inhibited OTUD4-induced ferroptotic cell death. Mechanistic studies indicated that OTUD4 functioned as an anti-proliferative and anti-metastasic factor through the regulation of RNA-binding protein 47 (RBM47)-mediated activating transcription factor 3 (ATF3). OTUD4 directly interacted with RBM47 and promoted its stability via deubiquitination events. RBM47 was critical in ccRCC progression by regulating ATF3 mRNA stability, thereby promoting ATF3-mediated ferroptosis. RBM47 interference abolished the suppressive role of OTUD4 overexpression in ccRCC. Our findings provide mechanistic insight into OTUD4 of ccRCC progression and indicate a novel critical pathway OTUD4/RBM47/ATF3 may serve as a potential therapeutic pathway for ccRCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Activating Transcription Factor 3Carcinoma, Renal CellKidney NeoplasmsRNA-Binding ProteinsAnimalsFemaleHumansMaleMiceMiddle AgedCell Line, TumorCell ProliferationDeubiquitinating EnzymesFerroptosisGene Expression Regulation, NeoplasticMice, NudeUbiquitin-Specific Proteases

Stichwörter der Autor:innen

ATF3Clear cell renal cell carcinomaOTUD4RBM47Ubiquitination

Substanzen

Activating Transcription Factor 3ATF3 protein, humanDeubiquitinating EnzymesRNA-Binding ProteinsUbiquitin-Specific ProteasesOTUD4 protein, humanRBM47 protein, human

Autor:innen und Institutionen

  • Department of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
  • School of Electrical Engineering of Zhengzhou University, Zhengzhou, China.
  • Center for Frontier Medical Engineering of Chiba University, Chiba, Japan.
  • Department of Urology, Guizhou Provincial People's Hospital, Guiyang, China.
  • Department of Pathology, Dalian Friendship Hospital, Dalian, China.
  • Department of Pharmacy, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.

Förderung

  • China Scholarship Council

Zitieren

APA

Li, Z., Tian, Y., Zong, H., Wang, X., Li, D., Keranmu, A., Xin, S., Ye, B., Bai, R., Chen, W., Yang, G., Ye, L., & Wang, S. (2024). Deubiquitinating enzyme OTUD4 stabilizes RBM47 to induce ATF3 transcription: a novel mechanism underlying the restrained malignant properties of ccRCC cells. Apoptosis. https://doi.org/10.1007/s10495-024-01953-6

Vancouver

Li Z, Tian Y, Zong H, Wang X, Li D, Keranmu A, et al. Deubiquitinating enzyme OTUD4 stabilizes RBM47 to induce ATF3 transcription: a novel mechanism underlying the restrained malignant properties of ccRCC cells. Apoptosis. 2024. doi:10.1007/s10495-024-01953-6

BibTeX
@article{Li2024,
  author = {Li, Ziyao and Tian, Ye and Zong, Huafeng and Wang, Xuelei and Li, Dongyang and Keranmu, Adili and Xin, Shiyong and Ye, Bowen and Bai, Rong and Chen, Weihua and Yang, Guosheng and Ye, Lin and Wang, Siyan},
  title = {Deubiquitinating enzyme OTUD4 stabilizes RBM47 to induce ATF3 transcription: a novel mechanism underlying the restrained malignant properties of ccRCC cells},
  journal = {Apoptosis},
  year = {2024},
  doi = {10.1007/s10495-024-01953-6}
}
Kostenlos starten →